Parkinson's disease and lactoferrin: Analysis of dependent protein networks

Gene Reports

Volumn 4, Issue , 2016, Pages 177-183

  Talebi, R ^a   Ahmadi, A ^a   Afraz, F ^b   Abdoli, R ^c  

^a BU ALI SINA UNIVERSITY   (Iran)

^b AGRICULTURAL BIOTECHNOLOGY RESEARCH INSTITUTE OF IRAN ABRII   (Iran)

^c UNIVERSITY OF GUILAN   (Iran)

Author keywords

In silico; Lactoferrin; Parkinson; Protein interaction network (PIN); SNCA

Indexed keywords

ALPHA SYNUCLEIN; LACTOFERRIN; PROTEIN; UBIQUINONE;

AMINO ACID SEQUENCE; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; HUMAN; MAXIMUM LIKELIHOOD METHOD; MOLECULAR PHYLOGENY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN INTERACTION NETWORK; SIGNAL TRANSDUCTION;

EID: 84974712436     PISSN: 24520144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genrep.2016.05.006     Document Type: Article

References (38)

1. M. Amiri, M. Jafari, S. AzimzadehJamalkandi, and S.M. Davoodi Atopic dermatitis-associated protein interaction network lead to new insights in chronic sulfur mustard skin lesion mechanisms Expert Rev. Proteomics. 10 5 2013 449 460 10.1586/14789450.2013.841548
2. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J. Royal Stat. Soc. 57 1 1995 289 300
3. F. Berlutti, F. Pantanella, T. Natalizi, A. Frioni, R. Paesano, A. Polimeni, and P. Valenti Antiviral properties of lactoferrin-a natural immunity molecule Molecules 16 8 2011 6992 7018 10.3390/molecules16086992
4. G. Bindea, B. Mlecnik, H. Hackl, P. Charoentong, M. Tosolini, A. Kirilovsky, W.H. Fridman, F. Pagès, Z. Trajanoski, and J. Galon ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks Bioinformatics 15 25(8) 2009 1091 1093 10.1093/bioinformatics/btp101
5. F. Bou-Abdallah Transferrins: molecular mechanisms of iron transport and disorders Biochim. Biophys. Acta 1820 3 2012 157 158 10.1016/j.bbagen.2012.01.009
6. F. Cabrera-Valdivia, F.J. Jiménez-Jiménez, J.A. Molina, P. Férnandez-Calle, A. Vázquez, F. Cañizares-Liébana, S. Larumbe-Lobalde, L. Ayuso-Peralta, M. Rabasa, and R. Codoceo Peripheral iron metabolism in patients with Parkinson's disease J. Neurol. Sci. 125 1 1994 82 86 10.1016/0022-510X(94)90246-1
7. S. Chandrasekaran, and D. Bonchev A network view on Parkinson's disease Comput. Struct. Biotechnol J. 7 2013 e201304004 10.5936/csbj.201304004
8. C.M. Clements, R.S. McNally, B.J. Conti, T.W. Mak, and J.P. Ting DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2 Proc. Natl. Acad. Sci. 103 41 2006 15091 15096
9. M.S. Cline, M. Smoot, E. Cerami, A. Kuchinsky, N. Landys, C. Workman, R. Christmas, I. Avila-Campilo, M. Creech, B. Gross, K. Hanspers, R. Isserlin, R. Kelley, S. Killcoyne, S. Lotia, S. Maere, J. Morris, K. Ono, V. Pavlovic, A.R. Pico, A. Vailaya, P.L. Wang, A. Adler, B.R. Conklin, L. Hood, M. Kuiper, C. Sander, I. Schmulevich, B. Schwikowski, G.J. Warner, T. Ideker, and G.D. Bader Integration of biological networks and gene expression data using Cytoscape Nat. Protoc. 2 10 2007 2366 2382
10. C.A. Davie A review of Parkinson's disease Br. Med. Bull. 86 2008 109 127 10.1093/bmb/ldn013
11. A. Dmitrienko, and D'Agostino Sr. R. Traditional multiplicity adjustment methods in clinical trials Stat. Med. 32 2013 5172 5218 10.1002/sim.5990 ()
12. Farlow J, Pankratz ND, Wojcieszek J, Foroud T. Parkinson disease overview. In: Pagon RA, Adam MP, Ardinger HH, et al. (eds) GeneReviews® [Internet]. Seattle, WA: University of Washington; 1993-2015. (2004 May 25 [updated 2014 Feb 27]).
13. A. García-Montoya, T.S. Cendón, S. Arévalo-Gallegos, and Q. Rascón-Cruz Lactoferrin a multiple bioactive protein: an overview Biochim. Biophys. 1820 3 2012 226 236 10.1016/j.bbagen.2011.06.018
14. A.J. Grau, V. Willig, W. Fogel, and E. Werle Assessment of plasma lactoferrin in Parkinson's disease Mov. Disord. 16 1 2001 131 134 10.1002/1531-8257(200101)16:1<131::AID-MDS1008>3.0.CO;2-O
15. H.M. Habib, W.H. Ibrahim, R. Schneider-Stock, and H.M. Hassan Camel milk lactoferrin reduces the proliferation of colorectal cancer cells and exerts antioxidant and DNA damage inhibitory activities Food Chem. 141 1 2013 148 152 10.1016/j.foodchem.2013.03.039
16. H.R. Ibrahim, T. Haraguchi, and T. Aoki Ovotransferrin is a redox-dependent autoprocessing protein incorporating four consensus self-cleaving motifs flanking the two kringles Biochim. Biophys. Acta 1760 3 2006 347 355 10.1016/j.bbagen.2005.11.025
17. D.T. Jones, W.R. Taylor, and J.M. Thornton The rapid generation of mutation data matrices from protein sequences Comput. Appl. Biosci. 8 3 1992 275 282 10.1093/bioinformatics/8.3.275
18. M.P. Joy, A. Brock, D.E. Ingber, and S. Huang High-betweenness proteins in the yeast protein interaction network J. Biomed. Biotechnol. 2005 2 2005 96 103 10.1155/JBB.2005.96
19. T. Kawamata, I. Tooyama, T. Yamada, D.G. Walker, and P.L. McGeer Lactotransferrin immunocytochemistry in Alzheimer and normal human brain Am. J. Pathol. 142 5 1993 1574 1585
20. S. Lesage, and A. Brice Parkinson's disease: from monogenic forms to genetic susceptibility factors Hum. Mol. Genet. 18 R1 2009 R48 R59 10.1093/hmg/ddp012
21. B. Leveugle, B.A. Faucheux, C. Bouras, N. Nillesse, G. Spik, E.C. Hirsch, Y. Agid, and P.R. Hof Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases Acta Neuropathol. 91 6 1996 566 572
22. G. Logroscino, K. Marder, J. Graziano, G. Freyer, V. Slavkovich, N. LoIacono, L. Cote, and R. Mayeux Altered systemic iron metabolism in Parkinson's disease Neurology 49 3 1997 714 717 10.1212/WNL.49.3.714
23. S. Lotia, J. Montojo, Y. Dong, G.D. Bader, and A.R. Pico Cytoscape app store Bioinformatics 29 10 2013 1350 1351 10.1093/bioinformatics/btt138
24. S. Maere, K. Heymans, and M. Kuiper BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks Bioinformatics 21 16 2005 3448 3449
25. M. Martins, A. Rosa, L.C. Guedes, B.V. Fonseca, K. Gotovac, S. Violante, T. Mestre, M. Coelho, M.M. Rosa, E.R. Martin, J.M. Vance, T.F. Outeiro, L. Wang, F. Borovecki, J.J. Ferreira, and S.A. Oliveira Convergence of miRNA expression profiling, α-synuclein interaction and GWAS in Parkinson's disease PLoS ONE 6 10 2011 e25443 10.1371/journal.pone.0025443
26. E.R. ÖztaşYeşim, and N. Özgüneş Lactoferrin: a multifunctional protein Adv. Mol. Med. 1 4 2005 149 154
27. Y.G. Park, J.K. Jeong, J.H. Lee, Y.J. Lee, J.W. Seol, S.J. Kim, T.Y. Hur, Y.H. Jung, S.J. Kang, and S.Y. Park Lactoferrin protects against prion protein-induced cell death in neuronal cells by preventing mitochondrial dysfunction Int. J. Mol. Med. 31 2 2013 325 330 10.3892/ijmm.2012.1198
28. H. Rakshit, N. Rathi, and D. Roy Construction and analysis of the protein-protein interaction networks based on gene expression profiles of Parkinson's disease PLoS ONE 9 8 2014 e103047 10.1371/journal.pone.0103047
29. M. Ray, J. Ruan, and W. Zhang Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases Genome Biol. 9 10 2008 R148 10.1186/gb-2008-9-10-r148
30. D.C. Sévin, and U. Sauer Ubiquinone accumulation improves osmotic-stress tolerance in Escherichia coli Nat. Chem. Biol. 10 4 2014 266 272 10.1038/nchembio.1437
31. D. Szklarczyk, A. Franceschini, M. Kuhn, M. Simonovic, A. Roth, P. Minguez, T. Doerks, M. Stark, J. Muller, P. Bork, L.J. Jensen, and C. von Mering The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored Nucleic Acids Res. 39 2011 D561 D568 10.1093/nar/gkq973
32. K. Tamura, D. Peterson, N. Peterson, G. Stecher, M. Nei, and S. Kumar MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods Mol. Biol. Evol. 28 10 2011 2731 2739 10.1093/molbev/msr121
33. C.T. Teng, B.T. Pentecost, A. Marshall, A. Solomon, B.H. Bowman, P.A. Lalley, and S.L. Naylor Assignment of the lactotransferrin gene to human chromosome 3 and to mouse chromosome 9 Somat. Cell Mol. Genet. 13 6 1997 689 693
34. B.W. van der Strate, L. Beljaars, G. Molema, M.C. Harmsen, and D.K. Meijer Antiviral activities of lactoferrin Antivir. Res. 52 3 2001 225 239
35. L.L. Venda, S.J. Cragg, V.L. Buchman, and R. Wade-Martins α-Synuclein and dopamine at the crossroads of Parkinson's disease Trends Neurosci. 33 12 2010 559 568 10.1016/j.tins.2010.09.004
36. C. von Mering, L.J. Jensen, M. Kuhn, S. Chaffron, T. Doerks, B. Krüger, B. Snel, and P. Bork STRING 7-recent developments in the integration and prediction of protein interactions Nucleic Acids Res. 35 2007 D358 D362 10.1093/nar/gkl825
37. J. Wally, and S.K. Buchanan A structural comparison of human serum transferrin and human lactoferrin Biol. Met. 20 3-4 2007 249 262 10.1007/s10534-006-9062-7
38. H. Yu, P.M. Kim, E. Sprecher, V. Trifonov, and M. Gerstein The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics PLoS Comput. Biol. 3 4 2007 e59 10.1371/journal.pcbi.0030059